Laboratory Diagnosis of Cancer (M) Flashcards

1
Q

What are the methods for lab dx of CA?

A

1) Morphologic methods
a. Cytology
b. Tissue biopsy
c. Immunohistochemistry (IHC)
d. Flow cytometry
2) Biochemical assays
a. Tumor markers
3) Molecular dx
a. Polymerase chain reaction (PCR)
b. Fluorescence in-situ hybridization (FISH)
4) Molecular profiling
a. DNA-microarray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the methods under cytology?

A

1) Exfoliative cytology
a. Cervical Pap’s smear
b. Washings / Brushings
2) Fine needle aspiration biopsy (FNAB)
a. Fluids
i. Pleural
ii. Peritoneal
iii. CSF
iv. Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the methods under tissue biopsy?

A

1) Incision biopsy
2) Punch biopsy
3) Core biopsy
4) Cone biopsy
5) Excision biopsy
6) Tissue resection
7) Frozen section dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the characteristic IHC?

A

It is the basic battery to differentiate tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the tumor markers under IHC?

A

1) Cytokeratin
2) Vimentin
3) Leukocyte common antigen (LCA)
4) S-100 / NSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is flow cytometry?

A

It is a rapid and dynamic method of correlated multiparameter, single cell analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are flow cytometers?

A

These are instruments that determine the characteristics of the cells in a complex cell mixture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the action of flow cytometry?

A

It is designed to enhance microscopic analysis of individual cells using fluorescent substrates and probes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Flow cytometry is originally developed for what purpose?

A

For the purpose of sorting cells or fluorescence-activated cell sorting (FACS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism (/ principle / method) of flow cytometry?

A

1) A suspension of cells (or other biological
particles), either directly or indirectly labeled with
1 or more flourescent probes, is led in a stream
past an illumination and light detection system
2) The cells traverse the illumination spot one by one
3) When the jet stream intersects the laser beam,
fluorescent excitation occurs
4) A microscope objective projects the scatter and
fluorescence light that bounces off the cells to a set
of photomultipliers
5) Temporal, spatial and chromatic filters eliminate
background light and separate the signals from
different fluorophores
6) Digital acquisition electronics measure the
intensity of the light pulses
7) Each cell is measured for light scatter signals and
the presence or absence of fluorescence are
subsequently classified
8) A cell sorter adds a sorting mechanism to a flow
cytometer so that the cells can be separated after
they have been measured and classified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How cell sorting works (/ what is the method of how cell sorting works)?

A

1) Cells are suspended in a stream
2) Laser beams excite cell fluorescence
3) Signals are measured
4) Stream breaks into drops
5) Drops with cells are charged
6) Electrostatic field deflects drops
7) Drops with cells are collected
8) High speed cell sorters identify and select fluorescent particles at a rate of ~25,000 per second or 100,000,000 per hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What must be the characteristic of selected fluorochrome rgnts?

A

Those selected must be suitable for excitation by 488 nm light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the exs of fluorochrome rgnts?

A

1) Fluorescein isothiocyanate (FITC)
2) Phycoerythrin (PE)
3) Propidium iodide (PI)
4) 7-amino-actinomycin D (7AAD)
5) Peridin-chlorophyl-A-protein (PerCP)
6) Dimers of thiazole orange (TOTO-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the most commonly analyzed clinical materials (/ sxs) in flow cytometry?

A

1) Blood
2) Bone marrow aspirates
3) Lymph node suspensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the most frequently recommended technique used for sx preparation (for flow cytometry)?

A

Whole blood lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the recommended for preparing sxs for FC immunophenotyping of leukemias and lymphomas?

A

Whole blood lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is whole blood lysis (in terms of sx preparation for flow cytometry) done?

A

1) Incubation of a fixed volume of anticoagulated whole blood (or bone marrow) with one or more directly conjugated monoclonal antibodies followed by red blood cell lysis, washing, fixation in formaldehyde, and flow cytometric analysis
2) Gating is used for identifying cells/ particles of interest in a mixed population, e.g. non-lysed RBCs, platelets, debris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the advantages of doing whole blood lysis (in terms of sx preparation for flow cytometry)?

A

1) Fewer preparation steps
2) Less sx handling
3) Lower likelihood of differential cell loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the uses of flow cytometry?

A

1) Immunophenotyping for non-malignant disease
2) Characterization of lymphoid and myeloid malignancies
3) Hematopoietic stem cell enumeration
4) Red blood cell characterization
5) Platelet evaluation
6) Cell function testing
7) Cell cycle and apoptosis assessment
8) Human leukocyte antigen (HLA) typing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the clinical applications of flow cytometry?

A

1) Monitoring AIDS pts
2) Immunophenotyping leukemia and lymphomas and monitoring residual disease
3) Determining CD34 counts for hematopoietic reconstitution
4) Monitoring organ transplant pts for rejection
5) Reticulocyte counts
6) Dx of paroxysmal nocturnal hemoglobinuria (PNH)
7) DNA analysis of S-phase fraction of solid tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the characteristics of tumor markers (as used in biochemical assays)?

A

1) Nonspecific due to low sensitivity and specificity

2) Very effective in tumor staging, monitoring, and detecting recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the FDA approved kits in connection w/ tumor markers (w/c are being used in biochemical assays)?

A

1) Alpha fetoprotein (AFP)
2) Carcinoembryonic antigen (CEA)
3) ER
4) Cancer antigen (CA) 125
5) Prostate specific antigen (PSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the 2 major processes involved in growth (for tumor markers)?

A

1) Proliferation

2) Differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the characteristic of proliferation and differentiation?

A

Normally, these are well-regulated and under rigid control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the effect of loss of regulation (or / in proliferation and differentiation)?

A

Loss of the regulation increases the risk of these normal cells turning into tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Is there a tumor-specific marker that is developed and well-studied enough to be widely used in clinical practice?

A

None yet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

True or False

Any cell product may be used as a marker as long as it is related to any event during tumor formation

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

The clinical value of any given tumor marker will depend on what?

A

On the intended clinical use and the specificity and sensitivity of the tumor marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the types of tumor markers (in terms of identification)?

A

1) Associated w/ cell proliferation
2) Related to cell differentiation
3) Related to metastasis
4) Related to other tumor-associated events
5) Related to malignant transformation
6) Inherited mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the exs of tumor markers that are associated w/ cell proliferation?

A

1) Hormones
a. HCG
2) Serum proteins
3) Enzymes
4) Metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the characteristics of tumor markers w/c are associated w/ cell proliferation?

A

1) Their lvls are increased

2) These are more useful in monitoring pts during treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Why are the lvls of tumor markers w/c are associated w/ cell proliferation increased?

A

Due to high proliferation rate of the cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

True or False

Benign diseases may also involve elevated lvls of tumor markers (w/c are associated w/ cell proliferation), hence, they are not suitable for screening of for CA dx

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is the ex of tumor markers w/c are related to cell differentiation?

A

Most are carcinoembryonic proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the characteristics of tumor markers w/c are related to cell differentiation?

A

1) Measurement rely on immunoassay because their conc. in the serum is in nannogram/mL lvls
2) Correlates well w/ tumor activity and can be used to predict px
3) Generally, they are not suitable for screening because:
a. Polyclonal Ab directed against these proteins often cross-react w/ normal proteins
b. Do not appear sufficiently early in the blood from CA pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the uses of tumor markers w/c are related to cell differentiation?

A

1) These are used as adjunct in CA dx
2) These are very useful for monitoring success of treatment
3) These are very useful for detecting recurrence

37
Q

What are the concepts related to tumor markers w/c are related to metastasis?

A

1) Several steps are involved in metastasis
2) All cell products released during these steps are candidates to be a tumor marker
3) However, their measurement is still limited to tumor tissue / tumor cell cytosols

38
Q

What are the tumor markers w/c are related to other tumor-associated events?

A

These are glycosyltransferases w/ altered activities

39
Q

What are the exs of tumor markers w/c are related to other tumor-associated events?

A

1) Blood grp substances
2) Mucins
a. CA 19-9
3) α-fetoprotein / alpha fetoprotein (AFP) w/ additional fucose

40
Q

What is the characteristic of tumor markers w/c are related to other tumor-associated events?

A

These are tumor markers w/ altered enzymatic activities

41
Q

Why do tumor markers w/c are related to other tumor-associated events has altered enzymatic activities?

A

Due to tumor formation

42
Q

In relation w/ tumor markers w/c are related to malignant transformation, what are the genes that play a major role in cell transformation?

A

Oncogenes

43
Q

In relation w/ tumor markers w/c are related to malignant transformation, what is the mechanism of oncogenes that have lost their regulatory constraints on their activity?

A

Oncogenes that have lost their regulatory constraints on their activity may produce oncoproteins w/c have been used for px

44
Q

What are the exs of tumor markers w/c are related to malignant transformation?

A

1) c-erbB-2 protein

2) p185 protein

45
Q

True or False

In relation w/ tumor markers w/c are related to malignant transformation, since malignant transformation is a sp event in carcinogenesis, any cell product associated w/ this has the potential to be a more sp tumor marker

A

True

46
Q

What is the principle of inherited mutations?

A

Grp of suppressor genes that underwent mutations resulting to the production of inactive gene products (protein)

47
Q

What is the characteristic of inherited mutations?

A

These are usually found in families w/ increase risk of CA

48
Q

What are the exs of tumor markers w/c are related in inherited mutations?

A

1) p53
2) BRCA 1
3) BRCA 2

49
Q

What is the percentage of probability of occurrence of BRCA 1 (in relation w/ inherited mutations)?

A

50% of cases of inherited breast CA

50
Q

What is the status of risk of occurrence of BRCA 2 (in relation w/ inherited mutations)?

A

Increased risk of breast CA in males

51
Q

What are the uses of tumor markers w/c are related w/ inherited mutations?

A

These are useful for screening and identification of families and individuals at high risk

52
Q

What are the clinical applications of tumor markers?

A

1) Screening
2) Dx
3) Monitoring treatment
4) Detection of recurrence
5) For px

53
Q

True or False

In terms of clinical application of tumor markers, clinical utility of a tumor marker does not depend totally on its specificity and sensitivity

A

False, because clinical utility of a tumor marker depends almost totally on its specificity and sensitivity

54
Q

Is screening using tumor markers recommended in asymptomatic population? Why or why not?

A

No, due to low sensitivity, specificity, and prevalence of CA

55
Q

What are the exceptions related to screening (since screening using tumor markers is not recommended in asymptomatic population)?

A

1) Serum AFP to screen for primary hepatoma
2) CA 125 to screen for ovarian CA in women
3) PSA together w/ DRE to screen for prostate CA

56
Q

Are most tumor markers used in the dx of CA? Why or why not?

A

No, the use of most tumor markers in the dx of CA is discouraged due to their low specificity and sensitivity

57
Q

What is the effect if tumor markers are used for dx of CA?

A

There will be a fail to distinguish malignant from benign disease

58
Q

What are the schemes used to improve the diagnostic specificity of many tumor markers?

A

1) Use of multiple marker

2) Measurement of velocity and density in cases of prostate CA

59
Q

What is 1 of the 2 most useful application of tumor markers?

A

Monitoring treatment

60
Q

What is the effect of monitoring treatment brought by tumor markers?

A

It reflects well the success of surgery / efficacy of chemotherapy

61
Q

In terms of monitoring treatment (brought by tumor markers), detecting elevated lvls of tumor markers after surgery indicates what?

A

1) Incomplete removal
2) Recurrence
3) Metastasis

62
Q

What is the 2nd most useful application of tumor markers?

A

Detection of recurrence

63
Q

True or False

Ease of drawing blood and the sensitivity of tumor marker tests make the noninvasive monitoring process widely accepted (in connection w/ detection of recurrence brought by tumor markers)

A

True

64
Q

True or False

The specificity of tumor markers does not present a problem for this application (in relation w/ detection of recurrence brought by tumor markers)

A

True

65
Q

True or False

Assessment of tumor aggressiveness and px does not help in the development of a proper therapy (in relation w/ px brought by tumor markers)

A

False, because assessment of tumor aggressiveness and px helps in the development of a proper therapy

66
Q

In terms of px, what happens to most tumor markers when the tumor metastasizes?

A

Most tumor markers become increasingly elevated when the tumor metastasizes

67
Q

What is the characteristic of tumor markers w/c are highly associated w/ metastasis?

A

These are better markers for predicting px, but these tumor markers are still measured in tumor tissues and tissue cytosols

68
Q

What tumor marker should be used for px?

A

c-erbB-2 protein

69
Q

What are the types of assay (/ assay design)?

A

1) Competitive binding (/ competitive ELISA)

2) Sandwich format (/ sandwich ELISA)

70
Q

What is the mechanism of competitive binding?

A

Quantify many circulating tumor markers in the nano- and picogram/mL conc. ranges

71
Q

What is the principle of competitive binding?

A

It involves competition between a fixed amt of radioactively-labeled Ag and Ag in the sx for a limited amt of Ab

72
Q

In relation w/ competitive binding, any substances interfering w/ Ag-Ab binding can what?

A

Can falsely elevate the value

73
Q

What is the characteristic of sandwich format (/ ELISA using sandwich format)?

A

It has become the most popular method for tumor marker quantification

74
Q

What is the principle (/ method) of sandwich format?

A

1) A sp Ab is adsorbed in a solid phase, then a solution of Ag is added
2) After sufficient incubation and washing, an enzyme-labeled Ab is added to the solid phase
3) After washing unbound labeled-Ab, the remaining solid phase contains the Ag “sandwiched” between the Ab adsorbed to the solid phase and the labeled Ab

75
Q

What is the problem that may exist in sandwich format?

A

Hook effects

76
Q

In terms of comparison between monoclonal and polyclonal Ab, what Ab allows a more detailed immunochemical and molecular analysis of tumor markers?

A

Monoclonal Abs

77
Q

What are the effects that were eliminated if monoclonal Ab is combined w/ the solid phase of the sandwich test design?

A

1) Poor reproducibility
2) Lot-to-lot variations
3) Poor specificity
4) Poor cross-reactivity

78
Q

True or False

Whenever a monoclonal Ab is available, its use is recommended (in relation w/ the comparison between monoclonal and polyclonal Ab)

A

True

79
Q

What are the associated CAs of the given tumor marker?

Given tumor marker: AFP

A

1) Hepatocellular carcinoma

2) Nonseminomatous testicular germ-cell tumors

80
Q

What are the associated CAs of the given tumor marker?

Given tumor marker: β- human chorionic gonadotropin (hCG)

A

1) Trophoblastic tumors

2) Choriocarcinoma

81
Q

What is the associated CA of the given tumor marker?

Given tumor marker: Calcitonin

A

Medullary carcinoma of the thyroid

82
Q

What are the associated CAs of the given tumor marker?

Given tumor marker: CEA

A

Carcinoma of the:

1) Lung
2) Pancreas
3) Stomach
4) Breast
5) Colon

83
Q

What is the associated CA of the given tumor marker?

Given tumor marker: CA-125

A

Ovarian CA

84
Q

What is the associated CA of the given tumor marker?

Given tumor marker: CA 19-9

A

Pancreatic CA

85
Q

What is the associated CA of the given tumor marker?

Given tumor marker: Placental alkaline phosphatase (PLAP)

A

Seminoma

86
Q

What is the associated CA of the given tumor marker?

Given tumor marker: Prostatic acid phosphatase

A

Prostate CA

87
Q

What is the associated CA of the given tumor marker?

Given tumor marker: PSA

A

Prostate CA

88
Q

What are the associated CAs of the given tumor marker?

Given tumor marker: S-100

A

1) Melanoma
2) Neural-derived tumors
3) Astrocytoma

89
Q

What is the associated CA of the given tumor marker?

Given tumor marker: Tartrate- resistant acid phosphatase (TRAP)

A

Hairy cell leukemia